Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Emberson

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Kidney International|April 22, 2019
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.
Eclinicalmedicine|November 12, 2021
Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trialsNatalie Staplin, Alistair J Roddick, Jonathan Emberson, et al.
Kidney International Reports|August 4, 2023
Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP)William G Herrington, Charlie Harper, Natalie Staplin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 20, 2015
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKDRachael L Morton, Iryna Schlackow, Natalie Staplin, et al.
The New England Journal of Medicine|May 5, 2016
Perioperative Rosuvastatin in Cardiac SurgeryZhe Zheng, Raja Jayaram, Lixin Jiang, et al.
Journal of the American Society of Nephrology : JASN|October 31, 2020
Conventional and Genetic Evidence on the Association between Adiposity and CKDPengfei Zhu, William G Herrington, Richard Haynes, et al.
Ebiomedicine|April 25, 2018
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled TrialAntonio J Berlanga-Taylor, Katharine Plant, Andrew Dahl, et al.
European Heart Journal|October 4, 2023
Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trialRohan S Wijesurendra, Rebecca Sardell, Raja Jayaram, et al.
Heart (British Cardiac Society)|August 7, 2017
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2014
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)Richard Haynes, Natalie Staplin, Jonathan Emberson, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Kidney International|April 22, 2019
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.
Eclinicalmedicine|November 12, 2021
Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trialsNatalie Staplin, Alistair J Roddick, Jonathan Emberson, et al.
Kidney International Reports|August 4, 2023
Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP)William G Herrington, Charlie Harper, Natalie Staplin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 20, 2015
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKDRachael L Morton, Iryna Schlackow, Natalie Staplin, et al.
The New England Journal of Medicine|May 5, 2016
Perioperative Rosuvastatin in Cardiac SurgeryZhe Zheng, Raja Jayaram, Lixin Jiang, et al.
Journal of the American Society of Nephrology : JASN|October 31, 2020
Conventional and Genetic Evidence on the Association between Adiposity and CKDPengfei Zhu, William G Herrington, Richard Haynes, et al.
Ebiomedicine|April 25, 2018
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled TrialAntonio J Berlanga-Taylor, Katharine Plant, Andrew Dahl, et al.
European Heart Journal|October 4, 2023
Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trialRohan S Wijesurendra, Rebecca Sardell, Raja Jayaram, et al.
Heart (British Cardiac Society)|August 7, 2017
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2014
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)Richard Haynes, Natalie Staplin, Jonathan Emberson, et al.
Pageof 11